Andreas L. Birkenfeld, et.al., Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice., Cell metabolism, 2011, 14

http://rdf.ncbi.nlm.nih.gov/pubmed/21803289

Andreas L. Birkenfeld, et.al., Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice., Cell metabolism, 2011, 14

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Slc13a5<tm1Helf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5293233
• Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5293235
• Slc13a5<tm1.1Helf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5293234

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased carbon dioxide production_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0008963B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal metabolism_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0005266B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased body length_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0001258B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal glucose homeostasis_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0002078B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal liver physiology_Slc13a5<tm1.2Helf>/Slc13a5<+>
  http://metadb.riken.jp/0000609B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5Slc13a5Slc13a5tm12Helf
• decreased susceptibility to age related obesity_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0003213B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased body weight_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0001262B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal liver physiology_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0000609B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased susceptibility to diet-induced obesity_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0005659B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• increased energy expenditure_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0004889B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• hyperactivity_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0001399B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased liver triglyceride level_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0009356B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal hepatocyte physiology_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0010080B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased circulating glucose level_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0005560B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased body weight_Slc13a5<tm1.2Helf>/Slc13a5<+>
  http://metadb.riken.jp/0001262B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5Slc13a5Slc13a5tm12Helf
• decreased circulating lactate level_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0013404B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased circulating insulin level_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0002727B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• increased lean body mass_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0003960B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased body length_Slc13a5<tm1.2Helf>/Slc13a5<+>
  http://metadb.riken.jp/0001258B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5Slc13a5Slc13a5tm12Helf
• improved glucose tolerance_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0005292B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• increased muscle cell glucose uptake_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0030021B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal susceptibility to weight gain_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0011117B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal muscle physiology_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0002106B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal glycerol level_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0003439B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• decreased total body fat amount_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0010025B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• increased oxygen consumption_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0005289B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• increased insulin sensitivity_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0002891B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal hepatocyte morphology_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0000607B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf
• abnormal liver morphology_Slc13a5<tm1.2Helf>/Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/0000598B6CgSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12HelfSlc13a5tm12Helf

class

http://purl.org/net/cito/citesAsAuthority

• Slc13a5<tm1Helf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5293233
• Slc13a5<tm1.2Helf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5293235
• Slc13a5<tm1.1Helf>
  http://metadb.riken.jp/db/mgi_rdf/MGI:5293234